Launch of the KEMSA Strategic Plan 2015-2019
Principal Secretary, colleagues, it is a pleasure and an honor to be with you today to launch our groundbreaking new partnership, the USAID-KEMSA Medical Commodities Program. This program is funded by the American people through the U.S. President’s Emergency Plan for AIDS Relief, the President’s Malaria Initiative, and USAID’s Global Health Programs. But here’s what’s truly important: our new partnership will help millions of Kenyans get life-saving drugs more quickly and efficiently. We should all be proud of this new, landmark partnership that demonstrates the benefits of hard work and dedication.
The United States has collaborated with Kenya for over 50 years on improving the health and wellbeing of the Kenyan people. Today, we take the next step. We sign and launch our new partnership, the Medical Commodities Program. Under this agreement, USAID will provide KSH 65 billion (US $650 million) to KEMSA to acquire and supply lifesaving drugs and commodities across the country. And I want to be clear about the historic nature of this agreement: this program represents the largest single bilateral award ever made by a USAID mission in the history of the agency. This historic award underscores the enduring commitment of the United States to the welfare of Kenyans.
While the Medical Commodities Program is a landmark in our assistance, it is also a major step in Kenya’s capacity to deliver health services to those who need help. Historically, the U.S. government and its partners have purchased medical supplies such as HIV test kits, antiretroviral drugs, contraceptives, and malaria medicines and then distributed them across the country. With this program, KEMSA will procure and distribute these supplies directly. And, as a result, millions of Kenyans will receive high-quality medicine and treatment faster and more efficiently.
The Medical Commodities Program represents a significant shift in the way we are doing business in Kenya. But, I also want to be clear about one other critical point. While we have confidence in KEMSA to manage this program funded by the American people, we have also taken strong steps to ensure there is full transparency and accountability. We will have extensive oversight. Integrity and efficiency in this program is not just something we hope for; it is something we require – and we know it is something Kenyans demand as well.
We do so because, as we all know, corruption is a crisis in Kenya. As I have said frequently, it is undermining the country’s future. Corruption threatens Kenya’s economic growth, the provision of government services, and security. It threatens the country’s health care system. It must end. And for that to happen all public programs must live up to the highest standards. There must be zero tolerance for corruption. Public funds must go to their intended beneficiaries – in this case patients suffering from life-threatening diseases – and not into the pockets of officials who betray the public trust. The United States’ position on this problem is very clear: all allegations of corruption must be investigated; and when evidence is found officials must be prosecuted and, if guilty, sent to prison regardless of their position or wealth. Ending corruption is first a task for leaders, but it is also the responsibility of everyone, all Kenyans. And, as a friend, the United States will do all it can to help, as promised in the joint commitment issued during President Obama’s historic visit.
Our new program with KEMSA is a testament to our confidence in the organization. Receiving funds from the U.S. Government is not easy and effectively managing resources on this large scale is even harder. To ensure KEMSA is able to take on its new responsibilities and succeed, we have invested in its systems and its people for the past 13 years. The U.S. government has supported KEMSA in its efforts to improve its ability to manage procurement, storage, and distribution of medical equipment, including life-saving test kits and medication for child and maternal health, HIV/AIDS, and malaria.
KEMSA has undergone regular audits and had significant oversight under the watchful eye of an accounting firm. KEMSA’s management systems have been strengthened to include the development of specific inventory control systems to improve the transparency of its business practices. Under the new contract, KEMSA will be audited and each expenditure will be agreed upon and approved in advance by a U.S. contracting officer. Each sub-contract KEMSA awards will also be approved by USAID. To sum it up, and to paraphrase a former American President, we will “trust but verify.” We recognize KEMSA as a center of excellence for health service delivery across the continent and we are giving KEMSA the resources to put its skills to work for the people of Kenya. But we will also continue to work closely with KEMSA to ensure our shared goal – the efficient and rapid delivery of life-saving medicines and commodities to the people of Kenyautton”